In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Gene name</td><td class="align_center">Primer sequences</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left" rowspan="2">VEGF</td><td class="align_center">Forward: 5ʹ-ATCGAGTACATCTTCAAGCCAT-3ʹ</td></tr><tr><td class="align_center">Reverse: 5ʹ-GTGAGGTTTGATCCGCATAATC-3ʹ</td></tr><tr><td class="align_left" rowspan="2">Flt-1</td><td class="align_center">Forward: 5ʹ-CAAGATTTGCAGAACTTGTGGA-3ʹ</td></tr><tr><td class="align_center">Reverse: 5ʹ-CTGTCAGTATGGCATTGATTGG-3ʹ</td></tr><tr><td class="align_left" rowspan="2">KDR</td><td class="align_center">Forward: 5ʹ-GGAGCTTAAGAATGCATCCTTG-3ʹ</td></tr><tr><td class="align_center">Reverse: 5ʹ-GATGCTTTCCCCAATACTTGTC-3ʹ</td></tr><tr><td class="align_left" rowspan="2">Col1A1</td><td class="align_center">Forward: 5ʹ-AAAGATGGACTCAACGGTCTC-3ʹ</td></tr><tr><td class="align_center">Reverse: 5ʹ-CATCGTGAGCCTTCTCTTGAG-3ʹ</td></tr><tr><td class="align_left" rowspan="2">GAPDH</td><td class="align_center">Forward: 5ʹ-AGACAGCCGCATCTTCTTGT-3ʹ</td></tr><tr><td class="align_center">Reverse: 5ʹ-CTTGCCGTGGGTAGAGTCAT-3ʹ</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Primers used in real-time polymerase chain reaction.</div>

Journal of Ophthalmology

tab2

Table 2

Table 2: In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery 

Table 2 | In Vitro Study of Combined Application of Bevacizumab and 5-Fluorouracil or Bevacizumab and Mitomycin C to Inhibit Scar Formation in Glaucoma Filtration Surgery 